DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Thursday 16 June 2016

Lori krim Gavrin

Lori Gavrin

Lori Gavrin

Discovery Partnerships with Academia; Sr. Director Collaboration Strategy; Esprit R&D at GSK

Links
LORI GAVRIN has 15 years’ experience as a Ph.D. organic chemist working in the field of drug discovery and development. As a member of GlaxoSmithKline’s highly selective R&D Esprit Leadership Development Program, she is working in the maternal and neonatal health unit in partnership with Save the Children to reduce the tragically high newborn mortality rate in the developing world by increasing access of lifesaving medicines to mothers and newborns. Previous to her current role, Dr. Gavrin has led R&D efforts in cystic fibrosis, diabetes, arthritis and women’s health.  She has more than a dozen publications and is a named inventor on 11 patents.  A passionate supporter of the research being done in the pharmaceutical and biotech industry, Dr. Gavrin recently chaired the world’s premier medicinal chemistry conference, the Gordon Research Conference, and has delivered numerous talks on the drug discovery and development process around the world to graduate students, professors, fellow industry members, and high school teachers.  Dr. Gavrin earned a B.S. at Colgate University and her Ph.D. in organic chemistry at University of Pennsylvania.  @gsk

Experience


Discovery Partnerships with Academia; Sr. Director Collaboration Strategy; Esprit R&D

GSK
– Present (11 months)Upper Providence, PA
This Discovery Partneships with Academia unit at GSK (dpac.gsk.com) aims to build integrated partnerships with academics that can translate innovative research into medicines to benefit patients. I will be responsible for developing an enhanced strategic and business development approach to academic collaborations for the Upper Providence-Philadelphia geography and will assume responsibility for portfolio management across the entire DPAc portfolio. I will also co-lead a 2015 Discovery Fast Track (gsk.com/discoveryfasttrack) winner and guide the project through the development of high through-put and triage assays.
Discovery Partnerships with Academia (DPAc) | GlaxoSmithKline
Discovery Partnerships with Academia (DPAc) | GlaxoSmithKline

Esprit Associate - Scientific Director in Maternal & Neonatal Health R&D

GSK
– (1 year 2 months)Stevenage, United Kingdom
Our R&D unit is developing a portfolio in the maternal and neonatal health therapeutic area and also has accountability for the R&D Workstream of the GSK-Save the Children Partnership. (http://www.gsk.com/about-us/corporate-partnerships/save-the-children-partnership.html?tab=taba-new-way-of-working)
Finding new ways to give mothers and newborns a healthier start
Finding new ways to give mothers and newborns a healthier start

Chair

2015 Medicinal Chemistry Gordon Research Conference
– (3 years 1 month)Colby Sawyer College, New Hampshire
The 2015 Medicinal Chemistry Gordon Research Conference will feature talks on the cutting edge of the discipline that include new compounds, targets and technologies that advance the science.

Esprit Associate - R&D Strategy

GlaxoSmithKline
– (1 year 3 months)Upper Merion, PA
R&D Strategy comprises a diverse group of experienced professionals who combine scientific knowledge, strong business acumen and an ability to drive strategy from concept to embedded change. The group maintains a keen awareness of internal and external R&D dynamics in order to effectively shape and continuously challenge the strategic direction of R&D through creative thinking, effective problem solving and strong stakeholder management

Senior Principal Scientist

Pfizer
– (3 years 8 months)Cambridge, MA

Principal Research Scientist

Wyeth Research
– (8 years 1 month)

Pfizer Research, Rare Disease Chemistry and Chemical Biology, BioTherapeutics Chemistry, 200 Cambridgepark Drive, Cambridge, USA
E-mail: lori.gavrin@pfizer.com
Tel: +1 617-665-5616

Education


Colgate University

BS, Organic Chemistry

Activities and Societies: Ice Hockey, Rugby

Holliston High School



 
 Dr. Lori Gavrin, Senior Director of Discovery Partnerships in Academia, hosted an energizing panel discussion, “Reviving Your Career: Actionable Steps to Achieve a Professional Renaissance”. Panelists included (left to right): Wendy Wallbridge, Leslye Louie, Patrice D’Eramo, and Kerry Hannon. Great job, Lori!

Lori Krim Gavrin, PhD

R&D Esprit Associate; Manager R&D Strategy and Portfolio
Esprit
Program at Penn: Organic Chemistry
Graduation Year: 2001

lorigavrin_crop.jpg
Describe your current position and firm/organization and the career path you took to get there
The Esprit R&D programme is all about developing future scientific leaders, with the knowledge, capabilities and behaviours to deliver our strategic R&D challenges. Lasting three years, this global development programme has been created to attract high-potential individuals and put them on a fast track to leadership.
Esprit Associate – Manager R&D Strategy and Portfolio, GlaxoSmithKline, 2013–Present
The Esprit R&D programme includes a diverse group of experienced professionals who combine scientific knowledge, strong business acumen and an ability to drive strategy from concept to embedded change. The group maintains a keen awareness of internal and external R&D dynamics in order to effectively shape and continuously challenge the strategic direction of R&D through creative thinking, effective problem solving and strong stakeholder management. My roles have included:
  1. Portfolio Analytics: Evaluation of Late Stage Assets: Prioritization of the very late stage studies (i.e., Ph 3b/4) with a goal of facilitating a sound cross-portfolio investment strategy which is critical for the delivery of our pipeline.
  2. Strategy & Programme Management: Innovation in Clinical Design (ICD) Project: Transforming the clinical development paradigm at GSK by driving more widespread utilization of novel trial designs to deliver meaningful patient-centered clinical results at a lower cost.  A member of the ICD strategy team; currently serving as Programme Manager for implementation of the program.
Prior to GSK, I served in Principal Scientist and Research Scientist roles at Wyeth/Pfizer:
Senior Principal Scientist, Pfizer, 2009–2013
  • Design Lead, Rare Disease Discovery Medicinal Chemistry
  • Team leader in collaboration with Cystic Fibrosis Foundation
  • Lab Head, Inflammation and Immunology Discovery Medicinal Chemistry
Principal Research Scientist, Wyeth Research, 2001–2009
  • Senior/Principal/Lead Research Scientist, Multiple TAs, Medicinal Chemistry
  • Initial member of start-up exploratory group
Skills/capabilities/knowledge that have been developed on current assignment
  • Strategic approach to problem solving
  • Transforming strategic programme output into a plan with implementable workstreams
  • Cross-functional portfolio and pipeline decision-making
  • Developed understanding of GSK R&D organizational structure through networking, discussions, interviews and many interactions with teams, scientists and leaders
  • Programme Management Tools and Skills
What skills, strengths, or knowledge did your graduate training provide you that helped you on your career path?
  • Scientific problem solving
  • Impactful drug design and medicinal chemistry knowledge
  • Collaboration and working with others; teamwork
  • Communication and clearly articulating your work – making a compelling argument (ie defending your thesis)
If other graduate students and postdocs wanted to get a position similar to yours, what 3 specific pieces of advice would you offer them that they can be doing now while still at Penn?
  • Don't be afraid of new challenges and pushing yourself beyond your "comfort zone"
  • The skills I learned from my chemistry background can be applied to different functional areas and, in fact, help me to provide diverse and valuable viewpoints
  • Communication, transparency and knowledge-sharing are key to your success
How can graduate students/postdocs at Penn find out more about your career field?
  • Check out the Esprit website: www.gsk.com/uk/careers/postgraduates/postgraduate-esprit-r-and-d-programme.html
  • GSK and other pharmaceutical companies are exploring new programs to develop scientists into leaders.  Explore all options.  Consider enrolling in one of these programs or moving outside your typical role for a secondment or rotation.  New skill sets will develop and distinguish you!
What do you most enjoy about your current position?
  • Being a scientific leader who can broaden horizons, invigorate scientists, empower decision making and create scientific influencers.
  • Positively impacting the strategic decisions that shape the future of GSK and our industry.
  • Aiding in changing the image of our industry and ultimately helping more patients around the world.
What are you looking forward to doing at work over the next week or two?
  • Learning something new every day.
  • Meeting new people and collaborating with new groups.

//////////
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)